Krensavage Asset Management, LLC Long-Term Concentrated

Location: New York, NY

CIK: 0001609251 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Nov 15, 2019

Total Value: $260M (100.0% shares, 0.0% debt)

Holdings (10)

UTHR United Therapeutics Corp 16.5%

Value $43.07M Shares 540,094 Est. Cost $126.32 Unrealized -36.2%

BIIB Biogen Inc 15.8%

Value $41.14M Shares 176,710 Est. Cost $314.89 Unrealized -26.1%

MCK McKesson Corp 15.4%

Value $40.08M Shares 293,297 Est. Cost $138.18 Unrealized -1.9%

GILD Gilead Sciences Inc 13.4%

Value $34.97M Shares 551,715 Est. Cost $53.09 Unrealized -4.0%

ENTA Enanta Pharmceuticals Inc 11.5%

Value $29.97M Shares 498,874 Est. Cost $38.94 Unrealized +90.8%

— Alexion Pharmaceuticals Inc 9.6%

Value $24.98M Shares 255,000 Est. Cost $97.94 Unrealized —

ELAN Elanco Animal Health Inc 9.1%

Value $23.73M Shares 892,620 Est. Cost $31.75 Unrealized -5.5%

— RTI Surgical HDS Inc 4.3%

Value $11.09M Shares 3,890,324 Est. Cost $4.39 Unrealized —

— Invacare Corp 3.5%

Value $9.186M Shares 1,224,761 Est. Cost $12.03 Unrealized —

AVNS Avanos Medical Inc 0.9%

Value $2.226M Shares 59,429 Est. Cost $64.35 Unrealized -40.7%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
UTHR	United Therapeutics Corp	540,094	$43.07M	16.5%	$126.32	-36.2%	COM	91307C102
BIIB	Biogen Inc	176,710	$41.14M	15.8%	$314.89	-26.1%	COM	09062X103
MCK	McKesson Corp	293,297	$40.08M	15.4%	$138.18	-1.9%	COM	58155Q103
GILD	Gilead Sciences Inc	551,715	$34.97M	13.4%	$53.09	-4.0%	COM	375558103
ENTA	Enanta Pharmceuticals Inc	498,874	$29.97M	11.5%	$38.94	+90.8%	COM	29251M106
—	Alexion Pharmaceuticals Inc	255,000	$24.98M	9.6%	$97.94	—	COM	015351109
ELAN	Elanco Animal Health Inc	892,620	$23.73M	9.1%	$31.75	-5.5%	COM	28414H103
—	RTI Surgical HDS Inc	3,890,324	$11.09M	4.3%	$4.39	—	COM	74975N105
—	Invacare Corp	1,224,761	$9.186M	3.5%	$12.03	—	COM	461203101
AVNS	Avanos Medical Inc	59,429	$2.226M	0.9%	$64.35	-40.7%	COM	05350V106